{"transactions":[{"id":753194,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T20:30:34.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":18518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended (the \"Plan\"). Such\nshares shall vest in accordance with the terms and conditions of the Plan and the reporting person's restricted stock award agreement."}],"balance_after":26423,"source":{"system":"sec-edgar","filing":"0001597334-26-000002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000159733426000002/ownership.xml","form_type":"4"}},{"id":957624,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-30T21:40:31.000Z","date":"2025-12-23","kind":"grant","planned":false,"acquired":true,"shares":7633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended (the \"Plan\"). Such\nshares shall vest in accordance with the terms and conditions of the Plan and the reporting person's restricted stock award agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 29, 2025, the common stock of the Issuer began trading on a split-adjusted basis, pursuant to which every 15 shares of issued and outstanding common stock\nwere reclassified as one share of common stock (the \"January Reverse Stock Split\"). On October 28, 2025, the common stock of the Issuer began trading on a split-adjusted\nbasis, pursuant to which every 12 shares of issued and outstanding common stock were reclassifed as one share of common stock (the\"October Reverse Stock Split\"\ntogether with the January Reverse Stock Split, the \"Reverse Stock Splits\"). The number of securities reported in this Form 4 has been adjusted to reflect the Reverse Stock\nSplits."}],"balance_after":7904,"source":{"system":"sec-edgar","filing":"0001193125-25-337179","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000119312525337179/ownership.xml","form_type":"4"}},{"id":1387825,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-11T23:14:11.000Z","date":"2024-10-09","kind":"grant","planned":false,"acquired":true,"shares":47733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan, as amended (the \"Plan\"). Such shares shall vest in full on December 31, 2024, subject to the terms and conditions of the Plan and the reporting person's restricted stock award agreement."}],"balance_after":48733,"source":{"system":"sec-edgar","filing":"0001415889-24-025055","document":"form4-10112024_111008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000141588924025055/form4-10112024_111008.xml","form_type":"4"}},{"id":1778114,"issuer":{"id":8193,"kind":"organization","name":"Enveric Biosciences, Inc."},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-19T21:34:00.000Z","date":"2023-09-15","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.14,"value":2140.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001415889-23-013430","document":"form4-09192023_090952.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/890821/000141588923013430/form4-09192023_090952.xml","form_type":"4"}},{"id":2497114,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF BUSINESS OFFICER"}}],"security":"Ordinary Shares","published_at":"2021-11-24T01:25:39.000Z","date":"2021-11-19","kind":"tax_withholding","acquired":false,"shares":3779,"price":8.36,"value":31592.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":429783,"source":{"system":"sec-edgar","filing":"0001415889-21-005470","document":"form4-11232021_051132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000141588921005470/form4-11232021_051132.xml","form_type":"4"}},{"id":2591892,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-08-24T22:57:44.000Z","date":"2021-08-20","kind":"tax_withholding","acquired":false,"shares":3779,"price":14.05,"value":53094.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":433562,"source":{"system":"sec-edgar","filing":"0001179110-21-008396","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021008396/edgar.xml","form_type":"4"}},{"id":2698230,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-05-24T22:12:29.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":3779,"price":17.8,"value":67266.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021."}],"balance_after":437341,"source":{"system":"sec-edgar","filing":"0001179110-21-005844","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021005844/edgar.xml","form_type":"4"}},{"id":2838139,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-23T23:09:15.000Z","date":"2021-02-20","kind":"tax_withholding","acquired":false,"shares":26961,"price":18.79,"value":506597.19,"ownership":{"direct":true},"balance_after":439719,"source":{"system":"sec-edgar","filing":"0001179110-21-002164","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021002164/edgar.xml","form_type":"4"}},{"id":2868535,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Business Officer"}}],"security":"Ordinary Shares","published_at":"2021-02-10T22:45:18.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":466680,"source":{"system":"sec-edgar","filing":"0001179110-21-001537","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911021001537/edgar.xml","form_type":"4"}},{"id":2967452,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2020-11-24T23:17:54.000Z","date":"2020-11-20","kind":"tax_withholding","acquired":false,"shares":4214,"price":17.21,"value":72522.94,"ownership":{"direct":true},"balance_after":401680,"source":{"system":"sec-edgar","filing":"0001179110-20-011369","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020011369/edgar.xml","form_type":"4"}},{"id":3048392,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2020-08-24T22:27:08.000Z","date":"2020-08-20","kind":"tax_withholding","acquired":false,"shares":4214,"price":18.22,"value":76779.08,"ownership":{"direct":true},"balance_after":405894,"source":{"system":"sec-edgar","filing":"0001179110-20-009267","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020009267/edgar.xml","form_type":"4"}},{"id":3136544,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2020-05-22T22:07:57.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":4214,"price":26.67,"value":112387.38,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,402 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2020."}],"balance_after":410108,"source":{"system":"sec-edgar","filing":"0001179110-20-006526","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020006526/edgar.xml","form_type":"4"}},{"id":3252011,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-25T00:10:17.000Z","date":"2020-02-20","kind":"tax_withholding","acquired":false,"shares":24392,"price":25.9,"value":631752.8,"ownership":{"direct":true},"balance_after":412920,"source":{"system":"sec-edgar","filing":"0001179110-20-002148","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020002148/edgar.xml","form_type":"4"}},{"id":3288129,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-06T00:00:35.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 3, 2020, the performance conditions applicable to 54,000 shares were achieved and such shares will vest on February 20, 2021, subject to the reporting person's continued service."}],"balance_after":437312,"source":{"system":"sec-edgar","filing":"0001179110-20-001202","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020001202/edgar.xml","form_type":"4"}},{"id":3288128,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-06T00:00:35.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":383312,"source":{"system":"sec-edgar","filing":"0001179110-20-001202","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911020001202/edgar.xml","form_type":"4"}},{"id":3360799,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2019-11-22T23:22:02.000Z","date":"2019-11-20","kind":"tax_withholding","acquired":false,"shares":2447,"price":17.6,"value":43067.2,"ownership":{"direct":true},"balance_after":318312,"source":{"system":"sec-edgar","filing":"0001179110-19-012015","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019012015/edgar.xml","form_type":"4"}},{"id":3430790,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2019-08-22T22:02:36.000Z","date":"2019-08-20","kind":"tax_withholding","acquired":false,"shares":2335,"price":21.51,"value":50225.85,"ownership":{"direct":true},"balance_after":320759,"source":{"system":"sec-edgar","filing":"0001179110-19-009790","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019009790/edgar.xml","form_type":"4"}},{"id":3514653,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2019-05-22T22:09:58.000Z","date":"2019-05-20","kind":"tax_withholding","acquired":false,"shares":1604,"price":19.84,"value":31823.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019."}],"balance_after":323094,"source":{"system":"sec-edgar","filing":"0001179110-19-006524","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019006524/edgar.xml","form_type":"4"}},{"id":3638116,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-22T23:16:40.000Z","date":"2019-02-20","kind":"tax_withholding","acquired":false,"shares":4919,"price":27,"value":132813.0,"ownership":{"direct":true},"balance_after":323671,"source":{"system":"sec-edgar","filing":"0001179110-19-002418","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019002418/edgar.xml","form_type":"4"}},{"id":3670048,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-07T22:46:17.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 5, 2019, the performance conditions applicable to 47,250 shares were achieved and such shares will vest on February 20, 2020, subject to the reporting person's continued service."}],"balance_after":328590,"source":{"system":"sec-edgar","filing":"0001179110-19-001564","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019001564/edgar.xml","form_type":"4"}},{"id":3670047,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-07T22:46:17.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":281340,"source":{"system":"sec-edgar","filing":"0001179110-19-001564","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911019001564/edgar.xml","form_type":"4"}},{"id":3754218,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2018-11-21T22:45:06.000Z","date":"2018-11-20","kind":"tax_withholding","acquired":false,"shares":5735,"price":24.79,"value":142170.65,"ownership":{"direct":true},"balance_after":216340,"source":{"system":"sec-edgar","filing":"0001179110-18-013108","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018013108/edgar.xml","form_type":"4"}},{"id":3835535,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-22T23:33:59.000Z","date":"2018-08-20","kind":"tax_withholding","acquired":false,"shares":5735,"price":26.95,"value":154558.25,"ownership":{"direct":true},"balance_after":222075,"source":{"system":"sec-edgar","filing":"0001179110-18-010820","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018010820/edgar.xml","form_type":"4"}},{"id":3921627,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-22T23:02:12.000Z","date":"2018-05-20","kind":"tax_withholding","acquired":false,"shares":18424,"price":24.31,"value":447887.44,"ownership":{"direct":true},"balance_after":227810,"source":{"system":"sec-edgar","filing":"0001179110-18-007373","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018007373/edgar.xml","form_type":"4"}},{"id":3930234,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2018-05-16T23:04:18.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 865 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2018."}],"balance_after":246234,"source":{"system":"sec-edgar","filing":"0001179110-18-006937","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018006937/edgar.xml","form_type":"4"}},{"id":4039497,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2018-02-22T22:40:06.000Z","date":"2018-02-20","kind":"tax_withholding","acquired":false,"shares":4741,"price":29.09,"value":137915.69,"ownership":{"direct":true},"balance_after":211619,"source":{"system":"sec-edgar","filing":"0001179110-18-002610","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018002610/edgar.xml","form_type":"4"}},{"id":4057126,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2018-02-14T23:21:13.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":216360,"source":{"system":"sec-edgar","filing":"0001179110-18-002124","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911018002124/edgar.xml","form_type":"4"}},{"id":4152184,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2017-11-22T21:38:42.000Z","date":"2017-11-20","kind":"tax_withholding","acquired":false,"shares":5820,"price":28.58,"value":166335.6,"ownership":{"direct":true},"balance_after":207360,"source":{"system":"sec-edgar","filing":"0001179110-17-014564","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017014564/edgar.xml","form_type":"4"}},{"id":4226213,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2017-08-23T21:04:52.000Z","date":"2017-08-21","kind":"purchase","acquired":true,"shares":4000,"price":26.3397,"value":105358.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price per share for the open market purchase on August 21, 2017. The shares were purchased at prices ranging from $26.2499 to $26.4541 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer."}],"balance_after":213180,"source":{"system":"sec-edgar","filing":"0001179110-17-011785","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017011785/edgar.xml","form_type":"4"}},{"id":4227274,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2017-08-22T22:29:21.000Z","date":"2017-08-20","kind":"tax_withholding","acquired":false,"shares":5820,"price":27.4,"value":159468.0,"ownership":{"direct":true},"balance_after":209180,"source":{"system":"sec-edgar","filing":"0001179110-17-011749","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017011749/edgar.xml","form_type":"4"}},{"id":4307673,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Comm Ops Officer"}}],"security":"Ordinary Shares","published_at":"2017-05-24T00:00:11.000Z","date":"2017-05-20","kind":"tax_withholding","acquired":false,"shares":5820,"price":36.83,"value":214350.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2017."}],"balance_after":215000,"source":{"system":"sec-edgar","filing":"0001179110-17-007879","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017007879/edgar.xml","form_type":"4"}},{"id":4430686,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Global Head Acute Care Bus"}}],"security":"Ordinary Shares","published_at":"2017-02-23T00:07:10.000Z","date":"2017-02-20","kind":"tax_withholding","acquired":false,"shares":8762,"price":33.78,"value":295980.36,"ownership":{"direct":true},"balance_after":219118,"source":{"system":"sec-edgar","filing":"0001179110-17-002992","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017002992/edgar.xml","form_type":"4"}},{"id":4461143,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":42015,"kind":"person","name":"PASQUALONE FRANK","position":1,"cik":"0001597334","reported_name":"PASQUALONE FRANK","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP Global Head Acute Care Bus"}}],"security":"Ordinary Shares","published_at":"2017-02-09T00:08:15.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 13, 2016."}],"balance_after":227880,"source":{"system":"sec-edgar","filing":"0001179110-17-002000","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583107/000117911017002000/edgar.xml","form_type":"4"}}]}